Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

Clinical trial NCT07734649 · RECRUITING

Trial details

NCT number: NCT07734649
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Immunization Human Metapneumovirus Immunization Healthy Volunteers

Start date: 2026-07-22
Primary completion: 2028-05-03
Enrollment: 2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.